Randomized Phase 3 Trial of Decitabine Versus Patient's Choice With Physician's Advice of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia.

Trial Profile

Randomized Phase 3 Trial of Decitabine Versus Patient's Choice With Physician's Advice of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Sep 2015

At a glance

  • Drugs Decitabine (Primary) ; Cytarabine
  • Indications Acute myeloid leukaemia
  • Focus Registrational; Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 14 Sep 2015 Results (at 1-year follow-up)published in the Advances in Therapy.
    • 06 Nov 2013 Results for the Wilcoxon test (as a sensitivity analysis) presented at the 16th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
    • 20 Jul 2012 Results have been published in June 2012 issue of the Journal of Clinical Oncology according to an Astex Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top